Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.59 |
| ▸ | ACR | P10323 | 1/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL532765 | 1.00 | HPGD (0.70) | HPGDKMT2ASMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL7591660 | 0.90 | LMNA (0.75) | KMT2ASMN1; SMN2MEN1CYP1A2CYP2C9 | |
| SCHEMBL12608584 | 0.90 | LMNA (0.75) | KMT2ASMN1; SMN2MEN1CYP1A2CYP2C9 | |
| SCHEMBL28003430 | 0.90 | KMT2A (0.69) | HPGDKMT2ASMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL610755 | 0.90 | KMT2A (0.69) | HPGDKMT2ASMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL12633724 | 0.90 | LMNA (0.75) | KMT2ASMN1; SMN2MEN1CYP1A2CYP2C9 | |
| SCHEMBL9683516 | 0.90 | KMT2A (0.69) | HPGDKMT2ASMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL9666088 | 0.90 | LMNA (0.75) | KMT2ASMN1; SMN2MEN1CYP1A2CYP2C9 | |
| SCHEMBL10599787 | 0.90 | KMT2A (0.69) | HPGDKMT2ASMN1; SMN2MEN1CYP1A2 | |
| SCHEMBL14393071 | 0.89 | KMT2A (0.69) | HPGDKMT2ASMN1; SMN2MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117996-B2 | Self-assembly composition for pattern formation and pattern forming method | Oji Holdings Corporation (JP) | 2021-09-14 | — | — | US | disclosed |
| US-20190211130-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | Oji Holdings Corporation (JP) | 2019-07-11 | — | — | US | disclosed |
| EP-1719768-B1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | ASAHI KASEI PHARMA CORP (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20120015925-A1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | ASAHI KASEI PHARMA CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| US-7973030-B2 | Benzothiazepine and benzothiepine compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1719768-A1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | Asahi Kasei Pharma Corporation (JP) | 2006-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117996-B2 | Self-assembly composition for pattern formation and pattern forming method | IAPP, SAMM50, MAN1B1 | HPGD 4198/4885KMT2A 3948/4885SMN1; SMN2 1010/4885 |
| US-20190211130-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | IAPP, SAMM50, MAN1B1 | HPGD 4198/4885KMT2A 3948/4885SMN1; SMN2 1010/4885 |
| US-20120015925-A1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | SLC10A1, SREBF1, SPTLC1 | HPGD 3931/4885KMT2A 404/4885SMN1; SMN2 4162/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | HPGD 3807/4885KMT2A 486/4885SMN1; SMN2 4351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.